This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Coronavirus Clouds Diversified Chemical Industry Outlook
by Anindya Barman
Diversified chemicals companies are buffeted by a downturn in demand across major markets and raw material cost pressure due to coronavirus.
DuPont's (DD) Earnings and Revenues Top Estimates in Q2
by Zacks Equity Research
DuPont (DD) saw strength across food & beverage and health & wellness end markets in the second quarter.
DuPont (DD) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
DuPont's (DD) adjusted earnings of 70 cents per share for Q2 beat the Zacks Consensus Estimate of 59 cents.
DuPont (DD) Warms Up to Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Demand weakness across certain markets amid the coronavirus pandemic is likely to have impacted DuPont's (DD) sales in the second quarter.
Material ETFs Well Poised for Gains As Q2 Earnings Unfold
by Sweta Killa
The materials sector has shown remarkable performance after the reopening of the economy as industrials and business activities have picked up.
DuPont (DD) Develops GWP Product to Lower GHG Emissions
by Zacks Equity Research
DuPont (DD) aims to incorporate a decline in embodied carbon in an updated Environmental Product Declaration, with the launch of a reduced GWP Styrofoam brand insulation.
DuPont's Performance Building Solutions Launch Roof Protector
by Zacks Equity Research
DuPont (DD) Tyvek Roof Protector offers the ideal balance of protection and efficiency to get the job completed quickly, effectively and safely.
Here's Why You Should Hold Onto DuPont (DD) Stock for Now
by Zacks Equity Research
DuPont (DD) benefits from cost synergy savings, innovation-driven investment and actions to boost cash flows.
DuPont Stock Up 64% in 3 Months: What's Behind the Rally?
by Zacks Equity Research
DuPont (DD) is benefiting from cost and productivity improvement actions, new product launches and initiatives to boost cash flows.
Why You Should Retain DuPont (DD) Stock in Your Portfolio
by Zacks Equity Research
DuPont (DD) gains from cost-control actions and product launches amid headwinds from soft demand and nylon pricing pressure.
International Flavors April, May Sales Dip 7% on Coronavirus Woes
by Zacks Equity Research
International Flavors' (IFF) quarter-to-date top-line numbers down on prevalent pressure in certain end-market categories across few countries due to the coronavirus pandemic.
DuPont (DD) Shares Pop 60% in 3 Months: What's Driving It?
by Zacks Equity Research
DuPont (DD) gains from cost synergy savings, new product launches and actions to drive cash flows.
International Flavors (IFF) Beats on Q1 Earnings, Scraps View
by Zacks Equity Research
International Flavors (IFF) registers sales and earnings growth in Q1 on broad-based growth in Scent and Taste segments.
DuPont's (DD) Earnings & Revenues Surpass Estimates in Q1
by Zacks Equity Research
DuPont (DD) witnessed strength across protective garments, probiotics and food & beverage businesses in Q1.
DuPont's (DD) Q1 Earnings Beat Estimates, Sales Miss
by Zacks Equity Research
DuPont's (DD) adjusted earnings of 84 cents per share for Q1 beat the Zacks Consensus Estimate of 83 cents.
DuPont Inks Europe Distribution Deal With Endure Walls
by Zacks Equity Research
DuPont (DD) envisions that the collaboration would better suit its customers in Europe.
DuPont (DD) Gears Up for Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Benefits of cost synergy savings and productivity actions are expected to get reflected on DuPont's (DD) first-quarter results.
What Lies Ahead for Materials ETFs in Q1 Earnings?
by Sweta Killa
While the major players seem to have less chances of beating earnings estimates, investors could still bet on Q1 earnings via ETFs.
DuPont (DD) Issues Preliminary Q1 Results, Suspends 2020 View
by Zacks Equity Research
DuPont (DD) expects adjusted earnings per share of 82-84 cents and net sales of $5.2 billion for first-quarter 2020.
DuPont (DD) Poised on Productivity Actions & New Products
by Zacks Equity Research
While DuPont (DD) faces headwinds from weak demand and pricing, it is gaining from productivity improvement actions and new product launches.
Coronavirus Casts a Pall Over Diversified Chemical Industry
by Anindya Barman
Soft demand and raw material cost pressure due to coronavirus pose as headwinds to diversified chemicals companies.
Here's Why You Should Hold Onto DuPont (DD) Stock for Now
by Zacks Equity Research
DuPont (DD) gains from cost-control actions and product launches amid headwinds from soft demand and pricing pressure.
3 Must-Buy Stocks as Coronavirus Cases Spike (Revised)
by Zacks Equity Research
COVID-19 has increased the demand for ventilators and personal protective equipment, which can aid these three companies at large.
Chemical Industry Leads the World in Fight Against Coronavirus
by Anindya Barman
A number of chemical companies are ramping up production to address the surging demand for health, hygiene and safety products.
3 Must-Buy Stocks as Coronavirus Cases Spike
by Zacks Equity Research
COVID-19 has increased the demand for ventilators and personal protective equipment, which can aid these three companies at large.